Licensees Sought For Osteotech Grafton DBM; Firm Cuts Workforce By 5%
This article was originally published in The Gray Sheet
Osteotech aims to improve domestic sales of its Grafton demineralized bone matrix business by initiating licensing deals with large orthopedic players
You may also be interested in...
Smith & Nephew will enter the demineralized bone matrix (DBM) market in the third quarter through a distribution deal with Osteotech
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.